Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections
Open accessThe DOI matches its Crossref record; 273 of the 273 references it cites were found in a registry or an index.
Abstract
In recent years, the worldwide spread of the so-called high-risk clones of multidrug-resistant or extensively drug-resistant (MDR/XDR) Pseudomonas aeruginosa has become a public health threat. This article reviews their mechanisms of resistance, epidemiology, and clinical impact and current and upcoming therapeutic options. In vitro and in vivo treatment studies and pharmacokinetic and pharmacodynamic (PK/PD) models are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–273 of 273
Naesens, R., Vlieghe, E., Verbrugghe, W., Jorens, P. G., & Ieven, M. M. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-317 · Cited by 63
Tato, M., García-Castillo, M., Bofarull, A. M., & Cantón, R. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.07.004 · Cited by 63
Walkty, A. J., Lagacé-Wiens, P. R. S., Adam, H. J., Baxter, M. R., Karlowsky, J. A., Mulvey, M. R., McCracken, M., & Zhanel, G. G. (2016) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2016.10.003 · Cited by 63
Gómez-Zorrilla, S., Camoez, M., Tubau, F., Periche, E., Cañizares, R., Domínguez, M. Á., Ariza, J., & Peña, C. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03419-14 · Cited by 62
Self-citationSy, S. K. B., Zhuang, L., Sy, S., & Derendorf, H. (2018) · Clinical Pharmacokinetics · doi:10.1007/s40262-018-0705-y · Cited by 62
Utilization of Colistin for Treatment of Multidrug‐Resistant Pseudomonas aeruginosa
Sabuda, D. M., Laupland, K. B., Pitout, J. D. D., Dalton, B., Rabin, H. R., Louie, T., & Conly, J. M. (2008) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2008/743197 · Cited by 60
Eibergen, N. R., Moore, J. D., Mattmann, M. E., & Blackwell, H. E. (2015) · ChemBioChem · doi:10.1002/cbic.201500357 · Cited by 60
Ceftolozane/tazobactam for the treatment of XDR Pseudomonas aeruginosa infections
Escolà‐Vergé, L., Pigrau, C., Arcos, I. L., Arévalo, Á., Viñado, B., Campany, D., Larrosa, N., Nuvials, X., Ferrer, R., Len, Ó., et al. (2018) · Infection · doi:10.1007/s15010-018-1133-5 · Cited by 60
Rhee, E. G., Rizk, M. L., Calder, N. A., Nefliu, M., Warrington, S., Schwartz, M. S., Mangin, E. C., Boundy, K. E., Bhagunde, P. R., Colón‐González, F., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00280-18 · Cited by 60
Abdelraouf, K., Kabbara, S., Ledesma, K. R., Poole, K., & Tam, V. H. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr105 · Cited by 59
Rossitto, M., Fiscarelli, E. V., & Rosati, P. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00775 · Cited by 59
Mohamed, A. F. S., Kristoffersson, A., Karvanen, M., Nielsen, E. I., Cars, O., & Friberg, L. E. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv488 · Cited by 58
The Rrp6 C-terminal domain binds RNA and activates the nuclear RNA exosome
Wasmuth, E. V., & Lima, C. D. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1152 · Cited by 58
Torrens, G., Cabot, G., Ocampo-Sosa, A. A., Conejo, M. C., Zamorano, L., Navarro, F., Pascual, Á., Martı́nez-Martı́nez, L., & Oliver, A. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01282-16 · Cited by 56
Self-citationGómez‐Junyent, J., Benavent, E., Sierra, Y., Haj, C. E., Soldevila, L., Torrejón, B., Rigo-Bonnin, R. F., Tubau, F., Ariza, J., & Murillo, Ó. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.01.010 · Cited by 56
Samonis, G., Vardakas, K. Z., Kofteridis, D. P., Dimopoulou, D., Andrianaki, A. M., Chatzinikolaou, I., Katsanevaki, E., Maraki, S., & Falagas, M. E. (2014) · Infection · doi:10.1007/s15010-014-0635-z · Cited by 55
Sánchez-Diener, I., Zamorano, L., López-Causapé, C., Cabot, G., Mulet, X., Peña, C., del Campo, R., Cantón, R., Doménech‐Sánchez, A., Martínez-Martínez, L., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01586-17 · Cited by 55
Self-citationRodríguez-Núñez, O., Ripa, M., Morata, L., de la Calle, C., Cardozo, C., Fehér, C., Pellicé, M., Valcárcel, A., Puerta‐Alcalde, P., Marco, F., et al. (2018) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2018.07.010 · Cited by 55
Ghazi, I. M., Monogue, M. L., Tsuji, M., & Nicolau, D. P. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.10.008 · Cited by 54
Lazar, H., Horn, M. P., Zuercher, A. W., Imboden, M. A., Durrer, P., Seiberling, M., Pokorny, R., Hammer, C., & Lang, A. B. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01699-08 · Cited by 52
Greipel, L., Fischer, S., Klockgether, J., Dorda, M., Mielke, S., Wiehlmann, L., Cramer, N., & Tümmler, B. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00724-16 · Cited by 52
Phages & Antibiotic Resistance: Are the Most Abundant Entities on Earth Ready for a Comeback?
Hill, C., Mills, S., & Ross, R. P. (2018) · Future Microbiology · doi:10.2217/fmb-2017-0261 · Cited by 52
Sader, H. S., Flamm, R. K., Dale, G. E., Rhomberg, P. R., & Castanheira, M. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky227 · Cited by 51
Ribera, A., Benavent, E., Lora-Tamayo, J., Tubau, F., Pedrero, S., Cabo, X., Ariza, J., & Murillo, Ó. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv281 · Cited by 50
Mano, Y., Saga, T., Ishii, Y., Yoshizumi, A., Bonomo, R. A., Yamaguchi, K., & Tateda, K. (2015) · BMC Microbiology · doi:10.1186/s12866-015-0378-8 · Cited by 49
Yadav, R., Bulitta, J. B., Nation, R. L., & Landersdorfer, C. B. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01011-16 · Cited by 49
Le, H. N., Quetz, J. D. S., Tran, V. G., Le, V. T. M., Aguiar-Alves, F., Pinheiro, M. G., Cheng, L., Yu, L., Sellman, B. R., Stover, C. K., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02565-17 · Cited by 49
Agnello, M., Finkel, S. E., & Wong‐Beringer, A. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01591 · Cited by 48
Botelho, J., Grosso, F., & Peixe, L. M. S. V. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx337 · Cited by 48
Monogue, M. L., & Nicolau, D. P. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx483 · Cited by 48
Characterization of a novel Zn2+-dependent intrinsic imipenemase from Pseudomonas aeruginosa
Fajardo-Lubian, A., Hernando‐Amado, S., Oliver, A., Ball, G., Filloux, A., & Martínez, J. L. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku267 · Cited by 47
Self-citationGómez-Zorrilla, S., Juan, C., Cabot, G., Camoez, M., Tubau, F., Oliver, A., Domínguez, M. Á., Ariza, J., & Peña, C. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.02.010 · Cited by 47
Self-citationDinh, A., Wyplosz, B., Kernéis, S., Lebeaux, D., Bouchand, F., Duran, C., Béraud, G., Lazaro, P., Davido, B., Hénard, S., et al. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.04.001 · Cited by 47
Rodvold, K. A., Gotfried, M. H., Chugh, R., Gupta, M., Patel, A. M., Chavan, R. P., Yeole, R. D., Friedland, H. D., & Bhatia, A. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00682-18 · Cited by 47
Karlowsky, J. A., Lob, S. H., Kazmierczak, K. M., Young, K., Motyl, M. R., & Sahm, D. F. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00169-18 · Cited by 46
Engineering therapeutic antibodies to combat infectious diseases
Wagner, E. K., & Maynard, J. A. (2018) · Current Opinion in Chemical Engineering · doi:10.1016/j.coche.2018.01.007 · Cited by 45
Pfaller, M. A., Shortridge, D., Sader, H. S., Castanheira, M., & Flamm, R. K. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.09.016 · Cited by 44
Dissemination of IMP-6-producing Pseudomonas aeruginosa ST244 in multiple cities in China
Chen, Y., Sun, M., Wang, M., Lu, Y., & Yan, Z. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2063-5 · Cited by 43
Arvanitis, M., Anagnostou, T., Kourkoumpetis, T. K., Ziakas, P. D., Desalermos, A. P., & Mylonakis, E. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089984 · Cited by 43
Long-term mortality following Pseudomonas aeruginosa bloodstream infection
McCarthy, K. L., & Paterson, D. L. (2016) · Journal of Hospital Infection · doi:10.1016/j.jhin.2016.11.014 · Cited by 43
Dietl, B., Sánchez, I., Arcenillas, P., Cuchí, E., Gómez, L., de Molina, F. J. G., Boix-Palop, L., Nicolás, J., & Calbo, E. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.11.003 · Cited by 43
Giamarellos‐Bourboulis, E. J., Plachouras, D., TZIVRA, A., Koussoulas, V., Bolanos, N., Raftogiannis, M., Galani, I., Dontas, I. A., Dionyssiou‐Asteriou, A., & Giamarellou, H. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2003.02365.x · Cited by 42
Guillamet, C. V., Vazquez, R., Noe, J., Micek, S. T., & Kollef, M. H. (2016) · Medicine · doi:10.1097/md.0000000000004708 · Cited by 41
Sorlí, L., Luque, S., Segura, C., Campillo, N., Montero, M., Esteve, E., Herrera, S., Benito, N., Álvarez-Lerma, F., Grau, S., et al. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-016-2117-7 · Cited by 41
Self-citationGoodlet, K. J., Nicolau, D. P., & Nailor, M. D. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01350-17 · Cited by 41
Peña, C., Gómez-Zorrilla, S., Suarez, C., Domínguez, M. Á., Tubau, F., Arch, O., Oliver, A., Pujol, M., & Ariza, J. (2012) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-012-1629-3 · Cited by 40
Self-citationOliver, W. D., Heil, E. L., Gonzales, J. P., Mehrotra, S., Robinett, K. S., Saleeb, P. G., & Nicolau, D. P. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02608-15 · Cited by 40
Wach, A., Dembowsky, K., & Dale, G. E. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02355-17 · Cited by 40
Xipell, M., Paredes, S., Fresco, L., Bodro, M., Marco, F., Martínez, J. A., & Soriano, À. (2018) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2018.01.010 · Cited by 40
Natesan, S., Pai, M. P., & Lodise, T. P. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx221 · Cited by 38
Botelho, J., Grosso, F., Quinteira, S., Mabrouk, A., & Peixe, L. M. S. V. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx143 · Cited by 37
Abdouchakour, F., Aujoulat, F., Licznar‐Fajardo, P., Marchandin, H., Toubiana, M., Parer, S., Lotthé, A., & Jumas‐Bilak, E. (2017) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2017.11.008 · Cited by 37
Vardakas, K. Z., Mavroudis, A. D., Georgiou, M., & Falagas, M. E. (2018) · Journal of Infection · doi:10.1016/j.jinf.2018.02.002 · Cited by 37
Montero, M., VanScoy, B. D., López-Causapé, C., Conde, H., Adams, J., Segura, C., Zamorano, L., Oliver, A., Horcajada, J. P., & Ambrose, P. G. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00026-18 · Cited by 37
Self-citationHakki, M., & Lewis, J. S. (2018) · Infection · doi:10.1007/s15010-018-1125-5 · Cited by 36
Dale, G. E., Halabi, A., Petersen‐Sylla, M., Wach, A., & Zwingelstein, C. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00490-18 · Cited by 35
Petitjean, M., Martak, D., Silvant, A., Bertrand, X., Valot, B., & Hocquet, D. (2017) · Microbial Genomics · doi:10.1099/mgen.0.000129 · Cited by 34
Brasseur, A., Hites, M., Roisin, S., COTTON, F. J., Vincent, J., Backer, D. D., Jacobs, F., & Taccone, F. S. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv491 · Cited by 30
Sader, H. S., Castanheira, M., Flamm, R. K., & Jones, R. N. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00405-16 · Cited by 30
Intraventricular CNS treatment with Colistin-Tigecycline combination: A case series
Tsolaki, V., Karvouniaris, M., Manoulakas, E., Kotlia, P., Karadontas, V., Fotakopoulos, G., Zakynthinos, E. G., & Makris, D. A. (2018) · Journal of Critical Care · doi:10.1016/j.jcrc.2018.07.025 · Cited by 29
Frattari, A., Savini, V., Polilli, E., Cibelli, D. C., Talamazzi, S., Bosco, D., Consorte, A., Fazii, P., & Parruti, G. (2018) · IDCases · doi:10.1016/j.idcr.2018.e00451 · Cited by 28
Juan, C., Conejo, M. C., Tormo, N., Gimeno, C., Pascual, Á., & Oliver, A. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks439 · Cited by 27
Self-citationBritt, N. S., Ritchie, D. J., Kollef, M. H., Burnham, C. D., Durkin, M. J., Hampton, N. B., & Micek, S. T. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02400-17 · Cited by 27
Walkty, A. J., Adam, H. J., Baxter, M. R., Lagacé-Wiens, P. R. S., Karlowsky, J. A., Hoban, D. J., & Zhanel, G. G. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx468 · Cited by 25
François, B., Chastre, J. E., Eggiman, P., Laterre, P., Torres, A., García, M. S., Esser, M. T., Bishop, B., Bonten, M. J. M., Goosens, H., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw245 · Cited by 24
Pre-clinical in vitro infection models
Drusano, G. L. (2017) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2017.09.011 · Cited by 23
Chronic hepatitis C infection and insulin resistance: two best friends
Abenavoli, L., & Almasio, P. L. (2011) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.11.72 · Cited by 22
Imberti, R., Iotti, G. A., & Regazzi, M. B. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.896740 · Cited by 21
Sy, S. K. B., Zhuang, L., Beaudoin, M., et al. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw535 · Cited by 20
Acute Inflammatory Response of Patients with Pseudomonas aeruginosa Infections: A Prospective Study
Gómez-Zorrilla, S., Morandeira, F., Castro, M. J., Tubau, F., Periche, E., Cañizares, R., Domínguez, M. Á., Ariza, J., & Peña, C. (2016) · Microbial Drug Resistance · doi:10.1089/mdr.2016.0144 · Cited by 15
Self-citationMolinaro, M., Morelli, P., Gregori, M. D., Gregori, S. D., Giardini, I., Tordato, F., Monzillo, V., Pocaterra, D., & Casari, E. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s169271 · Cited by 13
Impact of Multidrug Resistance on Experimental Empyema by Pseudomonas aeruginosa
Giamarellos‐Bourboulis, E. J., Tzepi, I., Tsovolou, I., Spyridaki, A., Τσαγανός, Θ., Vaki, I., Kotsaki, A., & Polychronopoulos, V. (2011) · Respiration · doi:10.1159/000326893 · Cited by 10
Heil, E. L., Lowery, A. V., Thom, K. A., & Nicolau, D. P. (2014) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1514 · Cited by 10
Cited by
Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis
Rossi, E., La Rosa, R., Bartell, J. A., Marvig, R. L., Haagensen, J. A. J., Sommer, L. M., Molin, S., & Johansen, H. K. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-00477-5 · Cited by 525
del Barrio-Tofiño, E., López-Causapé, C., & Oliver, A. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106196 · Cited by 372
Self-citationElfadadny, A., Ragab, R. F., AlHarbi, M., Badshah, F., Ibáñez-Arancibia, E., Farag, A., Hendawy, A. O., De los Ríos-Escalante, P. R., Aboubakr, M., Zakai, S. A., et al. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1374466 · Cited by 340
Multidrug-resistant Gram-negative bacterial infections
Macesic, N., Uhlemann, A.-C., & Peleg, A. Y. (2025) · The Lancet · doi:10.1016/s0140-6736(24)02081-6 · Cited by 315
Pseudomonas aeruginosa: Infections, Animal Modeling, and Therapeutics
Wood, S. J., Kuzel, T. M., & Shafikhani, S. H. (2023) · Cells · doi:10.3390/cells12010199 · Cited by 254
Metadata
- Authors
- Horcajada, J. P., Montero, M., Oliver, A., Sorlí, L., Luque, S., Gómez-Zorrilla, S., Benito, N., & Grau, S.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2019-09-18
- Volume
- 32
- Issue
- 4
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2970103499
- Cited by
- 961
- References
- 273
- FWCI
- 25.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.